Qian Cui

Zhongshan 2nd Road
Guangzhou, 510080, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.

ASO Visual Abstract: The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and Its Genomic Analysis.

Journal: Annals of surgical oncology
Published: August 11, 2026

Hypoxia-inducible factor 1-alpha: a dual regulator of ferroptosis in ischemic stroke and a promising therapeutic target.

Hypoxia-inducible factor 1-alpha: a dual regulator of ferroptosis in ischemic stroke and a promising therapeutic target.

Journal: Frontiers in neurology
Published: April 19, 2026

Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer.

Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: January 26, 2026

LAMPAD: An Integrated Circulating Tumor DNA-Based Model for Predicting Potential Cure in Patients With Resected NSCLC.

LAMPAD: An Integrated Circulating Tumor DNA-Based Model for Predicting Potential Cure in Patients With Resected NSCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 21, 2025

Correction: CLPTM1L interacts with ERLIN2 to stabilize SREBP1 and drive tumorigenesis in nasopharyngeal carcinoma.

Correction: CLPTM1L interacts with ERLIN2 to stabilize SREBP1 and drive tumorigenesis in nasopharyngeal carcinoma.

Journal: Cell death & disease
Published: August 26, 2025

The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis.

The Role of PD-L1 in Treatment Decision-Making for Perioperative EGFR-Mutated Lung Cancer and its Genomic Analysis.

Journal: Annals of surgical oncology
Published: August 15, 2025

EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.

EBV strain interacts with host HLA to drive nasopharyngeal carcinoma risk.

Journal: Nature
Published: July 14, 2025

Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations.

Neoadjuvant Immunochemotherapy in Resectable NSCLC With SMARCA4 Alterations.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 06, 2025

Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors.

Genomic profiling and pathological assessment of malignant peripheral nerve sheath tumors.

Journal: Journal of cancer research and clinical oncology
Published: December 02, 2024

CLPTM1L interacts with ERLIN2 to stabilize SREBP1 and drive tumorigenesis in nasopharyngeal carcinoma.

CLPTM1L interacts with ERLIN2 to stabilize SREBP1 and drive tumorigenesis in nasopharyngeal carcinoma.

Journal: Cell death & disease
Published: October 24, 2024

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma.

Radiomics-Based Support Vector Machine Distinguishes Molecular Events Driving the Progression of Lung Adenocarcinoma.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 02, 2024

Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population.

Genetic susceptibility of diffuse large B-cell lymphoma: a meta genome-wide association study in Asian population.

Journal: Leukemia
Published: June 08, 2024
Showing 1-12 of 38

Last Updated: 09/26/2026